Cargando…

Expression Profile Analysis Identifies a Novel Seven Immune-Related Gene Signature to Improve Prognosis Prediction of Glioblastoma

Glioblastoma multiform (GBM) is a malignant central nervous system cancer with dismal prognosis despite conventional therapies. Scientists have great interest in using immunotherapy for treating GBM because it has shown remarkable potential in many solid tumors, including melanoma, non-small cell lu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Li, Han, Zhibin, Cheng, Xingbo, Wang, Sida, Feng, Yumeng, Lin, Zhiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940837/ https://www.ncbi.nlm.nih.gov/pubmed/33708242 http://dx.doi.org/10.3389/fgene.2021.638458

Ejemplares similares

Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma
por: Zhang, Yesen, et al.
Publicado: (2022)

Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma
por: Yin, Wen, et al.
Publicado: (2019)

A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma
por: Wang, Junli, et al.
Publicado: (2021)

Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma
por: Ji, Hang, et al.
Publicado: (2022)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis
por: Zhang, Zhe, et al.
Publicado: (2023)

Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer
por: Liu, Xinyu, et al.
Publicado: (2022)

Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes
por: Qiu, Huaide, et al.
Publicado: (2020)

Tumor Characterization in Breast Cancer Identifies Immune-Relevant Gene Signatures Associated With Prognosis
por: Li, Jie, et al.
Publicado: (2019)

A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis
por: Li, Rang, et al.
Publicado: (2021)

Development and verification of the glycolysis-associated and immune-related prognosis signature for hepatocellular carcinoma
por: Hu, Bo, et al.
Publicado: (2022)

Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients
por: Dai, Siqi, et al.
Publicado: (2020)

Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma
por: Xue, Feng, et al.
Publicado: (2020)

Identifying Differential Expression Genes and Prognostic Signature Based on Subventricular Zone Involved Glioblastoma
por: Yuan, Qing, et al.
Publicado: (2022)

Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma
por: Du, Xuanlong, et al.
Publicado: (2020)

Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme
por: Sun, Ruohan, et al.
Publicado: (2021)

Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma
por: Jia, Hui, et al.
Publicado: (2023)

Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2022)

Distinguishing Glioblastoma Subtypes by Methylation Signatures
por: Zhang, Yu-Hang, et al.
Publicado: (2020)

Systematic Investigation of Immune-Related lncRNA Landscape Reveals a Potential Long Non-Coding RNA Signature for Predicting Prognosis in Renal Cell Carcinoma
por: Liu, Kepu, et al.
Publicado: (2022)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
por: Li, Jia, et al.
Publicado: (2022)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma
por: Wang, Guowei, et al.
Publicado: (2022)

Pyroptosis-Related Gene Signature Predicts the Prognosis and Immune Infiltration in Neuroblastoma
por: Li, Wanrong, et al.
Publicado: (2022)

Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
por: Tang, Pingfei, et al.
Publicado: (2021)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

Comprehensive analysis of the cancer driver genes constructs a seven-gene signature for prediction of survival and tumor immunity in hepatocellular carcinoma
por: Zou, Jun, et al.
Publicado: (2022)

Integrative Analysis Identifies a TNFα-Derived Gene Signature for Predicting Prognosis, Tumor Immunity, and Treatment Sensitivity in Gastric Cancer
por: Wang, Ke, et al.
Publicado: (2022)

Identification of Seven-Gene Hypoxia Signature for Predicting Overall Survival of Hepatocellular Carcinoma
por: Bai, Yuping, et al.
Publicado: (2021)

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Predicting prognosis and immunotherapy response among colorectal cancer patients based on a tumor immune microenvironment-related lncRNA signature
por: Hu, Chuling, et al.
Publicado: (2022)

Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma
por: Jin, Yi, et al.
Publicado: (2022)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
por: Chen, Cong, et al.
Publicado: (2022)

Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma
por: Chai, Xiu-kun, et al.
Publicado: (2021)

Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer
por: Xu, Jingxuan, et al.
Publicado: (2021)

Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma
por: Zou, Xiaoli, et al.
Publicado: (2022)

A pyroptosis-related gene signature for prognosis and immune microenvironment of pancreatic cancer
por: Tao, Sifan, et al.
Publicado: (2022)

Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer
por: Yang, Jiani, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j3njseejckpg72j6hi4puffiob